ATE520401T1 - Kombinationen aus einem beta-2-adrenozeptor- agonist und benzothiazolon - Google Patents

Kombinationen aus einem beta-2-adrenozeptor- agonist und benzothiazolon

Info

Publication number
ATE520401T1
ATE520401T1 AT08702047T AT08702047T ATE520401T1 AT E520401 T1 ATE520401 T1 AT E520401T1 AT 08702047 T AT08702047 T AT 08702047T AT 08702047 T AT08702047 T AT 08702047T AT E520401 T1 ATE520401 T1 AT E520401T1
Authority
AT
Austria
Prior art keywords
benzothiazolone
beta
combinations
adrenoceptor agonist
adrenoceptor
Prior art date
Application number
AT08702047T
Other languages
English (en)
Inventor
Elaine Bridget Cadogan
Stephen Connolly
David Nicholls
Katherine Wiley
Alan Young
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Application granted granted Critical
Publication of ATE520401T1 publication Critical patent/ATE520401T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425Thiazoles
    • A61K31/428Thiazoles condensed with carbocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/02Nasal agents, e.g. decongestants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/06Antiasthmatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/08Bronchodilators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pulmonology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT08702047T 2007-02-08 2008-02-06 Kombinationen aus einem beta-2-adrenozeptor- agonist und benzothiazolon ATE520401T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0702456.5A GB0702456D0 (en) 2007-02-08 2007-02-08 New combination
PCT/GB2008/000386 WO2008096111A1 (en) 2007-02-08 2008-02-06 Combinations of beta- 2 -adrenoceptor agonistic benzothiazolone

Publications (1)

Publication Number Publication Date
ATE520401T1 true ATE520401T1 (de) 2011-09-15

Family

ID=37898976

Family Applications (1)

Application Number Title Priority Date Filing Date
AT08702047T ATE520401T1 (de) 2007-02-08 2008-02-06 Kombinationen aus einem beta-2-adrenozeptor- agonist und benzothiazolon

Country Status (29)

Country Link
US (2) US20100029732A1 (de)
EP (2) EP2117542B1 (de)
JP (1) JP2010518056A (de)
KR (1) KR20090114391A (de)
CN (1) CN101652137A (de)
AR (1) AR065277A1 (de)
AT (1) ATE520401T1 (de)
AU (1) AU2008212713A1 (de)
BR (1) BRPI0806964A2 (de)
CA (1) CA2675465A1 (de)
CL (1) CL2008000379A1 (de)
CO (1) CO6210723A2 (de)
CY (1) CY1111932T1 (de)
DK (1) DK2117542T3 (de)
EC (1) ECSP099567A (de)
ES (1) ES2368967T3 (de)
GB (1) GB0702456D0 (de)
HR (1) HRP20110695T1 (de)
IL (1) IL199840A0 (de)
MX (1) MX2009007865A (de)
PE (1) PE20081759A1 (de)
PL (1) PL2117542T3 (de)
PT (1) PT2117542E (de)
RS (1) RS51956B (de)
RU (1) RU2009133255A (de)
SI (1) SI2117542T1 (de)
TW (1) TW200843750A (de)
UY (1) UY30906A1 (de)
WO (1) WO2008096111A1 (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW200738658A (en) 2005-08-09 2007-10-16 Astrazeneca Ab Novel compounds
TW200738659A (en) * 2005-08-29 2007-10-16 Astrazeneca Ab Novel compounds
TW200745067A (en) 2006-03-14 2007-12-16 Astrazeneca Ab Novel compounds
TW200825084A (en) 2006-11-14 2008-06-16 Astrazeneca Ab New compounds 521
TW200833670A (en) 2006-12-20 2008-08-16 Astrazeneca Ab Novel compounds 569
GB0702458D0 (en) 2007-02-08 2007-03-21 Astrazeneca Ab Salts 668
EP2300464A1 (de) 2008-05-13 2011-03-30 AstraZeneca AB Chinuklidinderivate als antagonisten des muskarin-m3-rezeptors
AU2009247021B2 (en) * 2008-05-13 2012-06-07 Astrazeneca Ab Pharmaceutical product comprising a muscarinic receptor antagonist and a beta2-adrenoceptor agonist
KR20110017456A (ko) 2008-06-18 2011-02-21 아스트라제네카 아베 호흡기 장애의 치료를 위한 베타2-아드레날린성 수용체 효능제로서 작용하는 벤족사지논 유도체
WO2009154562A1 (en) * 2008-06-20 2009-12-23 Astrazeneca Ab Pharmaceutical composition comprising a 4-hydroxy-2-oxo-2, 3- dihydro-1, 3-benzothiazol-7-yl compound for modulation of beta2-adrenoreceptor activity
TW201036957A (en) 2009-02-20 2010-10-16 Astrazeneca Ab Novel salt 628
US9827212B2 (en) 2009-03-18 2017-11-28 The Trustees Of The University Of Pennsylvania Compositions and methods for treating asthma and other lung diseases
WO2011011060A1 (en) 2009-07-22 2011-01-27 Puretech Ventures Methods and compositions for treatment of disorders ameliorated by muscarinic receptor activation
US10265311B2 (en) 2009-07-22 2019-04-23 PureTech Health LLC Methods and compositions for treatment of disorders ameliorated by muscarinic receptor activation
WO2011061527A1 (en) 2009-11-17 2011-05-26 Astrazeneca Ab Combinations comprising a glucocorticoid receptor modulator for the treatment of respiratory diseases
GB201016912D0 (en) 2010-10-07 2010-11-24 Astrazeneca Ab Novel combination
UA115958C2 (uk) 2014-09-09 2018-01-10 Вектура Лімітед Препарат, що містить глікопіролат, спосіб та пристрій
RS59671B1 (sr) * 2015-05-04 2020-01-31 Astrazeneca Ab Derivati pirazola korisni kao inhibitori proteina koji aktivira 5-lipoksigenazu (flap)
US10933020B2 (en) 2018-09-28 2021-03-02 Karuna Therapeutics, Inc. Compositions and methods for treating disorders ameliorated by muscarinic receptor activation

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE378109B (de) 1972-05-19 1975-08-18 Bofors Ab
ES2165768B1 (es) 1999-07-14 2003-04-01 Almirall Prodesfarma Sa Nuevos derivados de quinuclidina y composiciones farmaceuticas que los contienen.
CO5300399A1 (es) 2000-02-25 2003-07-31 Astrazeneca Ab Heterocicliocs que contienen nitrogeno, proceso para su preparacion y composiciones farmaceuticas que los contienen
AR028948A1 (es) 2000-06-20 2003-05-28 Astrazeneca Ab Compuestos novedosos
SE0100902D0 (sv) 2001-03-15 2001-03-15 Astrazeneca Ab Compounds
SE0104251D0 (sv) 2001-12-14 2001-12-14 Astrazeneca Ab Novel compounds
SE0301569D0 (sv) 2003-05-27 2003-05-27 Astrazeneca Ab Novel compounds
SA04250253B1 (ar) 2003-08-21 2009-11-10 استرازينيكا ايه بي احماض فينوكسي اسيتيك مستبدلة باعتبارها مركبات صيدلانية لعلاج الامراض التنفسية مثل الربو ومرض الانسداد الرئوي المزمن
SE0302486D0 (sv) 2003-09-18 2003-09-18 Astrazeneca Ab Novel compounds
GB0324790D0 (en) 2003-10-24 2003-11-26 Astrazeneca Ab Amide derivatives
GB0402797D0 (en) * 2004-02-09 2004-03-10 Novartis Ag Organic compounds
SE0401762D0 (sv) 2004-07-05 2004-07-05 Astrazeneca Ab Novel compounds
CN101048407A (zh) 2004-09-03 2007-10-03 普莱希科公司 双环杂芳基pde4b抑制剂
CA2584413A1 (en) 2004-10-29 2006-05-04 Astrazeneca Ab Novel sulphonamide derivatives as glucocorticoid receptor modulators for the treatment of inflammatory diseases
US20090012051A1 (en) 2005-03-15 2009-01-08 Kyowa Hakko Kogyo Co., Ltd. External preparation
TW200738658A (en) * 2005-08-09 2007-10-16 Astrazeneca Ab Novel compounds
EP2069355A4 (de) 2006-07-19 2010-03-24 Astrazeneca Ab Neue trizyklische spiropiperidinverbindungen, ihre synthese und ihre verwendung als modulatoren der chemokinrezeptoraktivität

Also Published As

Publication number Publication date
CY1111932T1 (el) 2015-11-04
IL199840A0 (en) 2010-04-15
GB0702456D0 (en) 2007-03-21
TW200843750A (en) 2008-11-16
BRPI0806964A2 (pt) 2014-04-08
UY30906A1 (es) 2008-09-30
WO2008096111A1 (en) 2008-08-14
RS51956B (en) 2012-02-29
PT2117542E (pt) 2011-10-06
SI2117542T1 (sl) 2011-11-30
EP2117542A1 (de) 2009-11-18
EP2364704A1 (de) 2011-09-14
JP2010518056A (ja) 2010-05-27
PL2117542T3 (pl) 2011-12-30
EP2117542B1 (de) 2011-08-17
RU2009133255A (ru) 2011-03-20
US20100029732A1 (en) 2010-02-04
DK2117542T3 (da) 2011-10-31
MX2009007865A (es) 2009-07-31
AR065277A1 (es) 2009-05-27
HRP20110695T1 (hr) 2011-11-30
CA2675465A1 (en) 2008-08-14
ES2368967T3 (es) 2011-11-24
CL2008000379A1 (es) 2008-10-24
KR20090114391A (ko) 2009-11-03
CO6210723A2 (es) 2010-10-20
ECSP099567A (es) 2009-09-29
PE20081759A1 (es) 2009-01-31
CN101652137A (zh) 2010-02-17
US20080242649A1 (en) 2008-10-02
AU2008212713A1 (en) 2008-08-14

Similar Documents

Publication Publication Date Title
ATE520401T1 (de) Kombinationen aus einem beta-2-adrenozeptor- agonist und benzothiazolon
BRPI0818301A2 (pt) Composições e métodos para intensificar a função cognitiva
AT503053A3 (de) Kombination aus einem träger und einem wafer
BRPI0909776A2 (pt) bujão perfurável co-moldado e método para fabricação do mesmo
DE112008002974B8 (de) Masseanschlussfahne und Erdungsvorrichtung hiermit
BRPI1007541A2 (pt) dispositivo de perfuração de alargamento de furo e métodos para usar o mesmo
DE602008006010D1 (de) Scheibe für Motorrad
DE602006016101D1 (de) Resttonerfördervorrichtung bestehend aus einem gewickelten Kunststoffteil
DK2185552T3 (da) Dipeptoid-prodrugs og anvendelse heraf
BRPI0810525A2 (pt) Composições e métodos para a profilaxia e tratamento de dependência química
ME02675B (de) Neue cyclohexylaminderivate mit 2-adrenerger agonistischer und m3-muskarinischer antagonistischer wirkung
FR2920762B1 (fr) Materiau a proprietes photocatalytiques
IL232477A (en) Cyclohexylamine derivatives with the activity of beta 2-adrenergic agonist and 3m muscarinic antagonist
BRPI0814758A2 (pt) Piridinacarboxamida e derivados de benzamida como ligantes taar1
DE602009000812D1 (de) Ölabscheidevorrichtung und Turbotriebwerk umfassend diese Vorrichtung
DE602008000291D1 (de) Steckverbinder und Montageverfahren dafür
BRPI0916744A2 (pt) filtro de fluxo direto e método para fazer o mesmo
EP2360201A4 (de) Aminpolymerverbindung und lichtemittierendes element damit
DE602008004799D1 (de) Steckverbinder und Montageverfahren dafür
DK2325662T3 (da) Multi-indlæsnings- og multi-udlæsningsanalysator
DE502007004581D1 (de) Anordnung mit einem beschichteten piezoaktor
CR10430A (es) Aminothiazoles and their uses
DE112006002117A5 (de) Kabelhalter und Anordnung mit einem Kabelhalter
BRPI0820726A2 (pt) Pneumático e utilização do mesmo
BRPI0917375A2 (pt) composicoes e metodos para fornecimento de um beneficio

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 2117542

Country of ref document: EP